SCHEMBL27409356

SCHEMBL27409356

CCC(=O)Nc1csc2c(Cl)ncnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.41
FGFR4 P22455 1/20 0.41
KDM4E B2RXH2 4/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
ALDH1A1 P00352 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 3/20 0.35
PKM P14618 1/20 0.34
MAPK1 P28482 1/20 0.34
CCR6 P51684 1/20 0.34
MCL1 Q07820 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27244267 0.84 PKM (0.39) KDM4ESMN1; SMN2KMT2AHSD17B10MAPT
SCHEMBL27409347 0.81 FGFR1 (0.40) FGFR1FGFR4KDM4EHTTSMN1; SMN2
SCHEMBL27409362 0.76 PDPK1 (0.60) KDM4ELMNAHTTMEN1KMT2A
SCHEMBL27409375 0.75 AXL (0.35) PDPK1
SCHEMBL27409145 0.71 EGFR (0.42) MEN1KMT2APDE11A
SCHEMBL1492031 0.70 CHEK1 (0.35) ALDH1A1TP53MAPTMAPK1BRAF
SCHEMBL27409272 0.70 CASP1 (0.40) ALDH1A1RAB9AMAPTMAPK1GAA
SCHEMBL1492023 0.68 AXL (0.37) ALDH1A1MAPTMAPK1BRAF
SCHEMBL2235253 0.68 LMNA (0.37) LMNASMN1; SMN2ALDH1A1MAPTPKM
SCHEMBL2232622 0.67 MAPT (0.33) ALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, ENTPD5 FGFR1 2333/4885FGFR4 4016/4885KDM4E 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.